Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CALL
Winnebago Industries
WGO
$892M
| $21.1M | 0.01% |
434,900
+152,700
| +54% | +$7.89M |
|
1727
CALL
iShares US Aerospace & Defense ETF
ITA
$15.1B
| $21.1M | 0.01% |
212,600
+46,600
| +28% | +$4.8M |
|
1728
PUT
Cintas
CTAS
$79.8B
| $21.1M | 0.01% |
225,600
-183,200
| -45% | -$17.9M |
|
|
AKLI
1729
DELISTED
Akili Inc
AKLI
| $21.1M | 0.01% |
2,128,708
+1,268
| +0.1% | +$12.5K |
|
|
MRSH
1730
Marsh
MRSH
$89.6B
| $21.1M | 0.01% |
135,594
-73,219
| -35% | -$11.7M |
|
1731
Southern Copper
SCCO
$156B
| $21M | 0.01% |
+460,879
| New | +$26.3M |
|
1732
CALL
PBF Energy
PBF
$8.52B
| $21M | 0.01% |
724,100
+106,600
| +17% | +$3.33M |
|
1733
CALL
HF Sinclair
DINO
$16.7B
| $21M | 0.01% |
464,600
+127,700
| +38% | +$5.72M |
|
1734
Suncor Energy
SU
$77B
| $21M | 0.01% |
597,802
+324,018
| +118% | +$11.8M |
|
1735
Morgan Stanley
MS
$342B
| $20.9M | 0.01% |
275,439
-519,356
| -65% | -$42.5M |
|
1736
CALL
NetEase
NTES
$80.1B
| $20.9M | 0.01% |
224,400
-113,400
| -34% | -$10.8M |
|
1737
MDU Resources
MDU
$4.34B
| $20.9M | 0.01% |
2,040,707
+733,039
| +56% | +$7.45M |
|
1738
PUT
Unilever
UL
$134B
| $20.9M | 0.01% |
405,689
+8,889
| +2% | +$453K |
|
|
GOOS
1739
Canada Goose Holdings
GOOS
$854M
| $20.9M | 0.01% |
1,161,285
-84,648
| -7% | -$1.79M |
|
1740
Whirlpool
WHR
$2.7B
| $20.9M | 0.01% |
134,858
+37,158
| +38% | +$6.46M |
|
1741
Abbott
ABT
$193B
| $20.8M | 0.01% |
191,577
-634,822
| -77% | -$72.1M |
|
1742
CALL
MPLX
MPLX
$60.3B
| $20.8M | 0.01% |
712,300
+84,900
| +14% | +$2.72M |
|
1743
PUT
Enterprise Products Partners
EPD
$84B
| $20.8M | 0.01% |
851,500
+455,600
| +115% | +$12M |
|
1744
Rocket Pharmaceuticals
RCKT
$381M
| $20.7M | 0.01% |
1,507,839
-278,416
| -16% | -$3.32M |
|
1745
Intuitive Machines
LUNR
$3.05B
| $20.7M | 0.01% |
2,146,487
+16,685
| +0.8% | +$162K |
|
1746
Leidos
LDOS
$18B
| $20.7M | 0.01% |
205,851
-424,294
| -67% | -$44M |
|
1747
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$24.7B
| $20.7M | 0.01% |
1,581,473
+1,195,876
| +310% | +$27M |
|
|
UNIT
1748
CALL
Uniti Group
UNIT
$2.43B
| $20.7M | 0.01% |
2,199,100
+2,061,500
| +1,498% | +$23.8M |
|
|
GTPB
1749
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $20.7M | 0.01% |
2,112,795
-8
| -0% | -$78 |
|
|
PDCE
1750
DELISTED
PDC Energy, Inc.
PDCE
| $20.7M | 0.01% |
335,633
+281,807
| +524% | +$20.4M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.